机译:帕洛诺司琼联合地塞米松预防生殖细胞癌多日顺铂化疗患者化疗引起的恶心和呕吐
Division of Hematology–Oncology Indiana University School of Medicine Indiana University Cancer Center 535 Barnhill Drive Room 473 Indianapolis IN 46202-5289 USA;
Division of Hematology–Oncology Indiana University School of Medicine Indiana University Cancer Center 535 Barnhill Drive Room 473 Indianapolis IN 46202-5289 USA;
Department of Solid Tumor Oncology Taussig Cancer Center The Cleveland Clinic 9500 Euclid Avenue Cleveland OH 44195 USA;
Oregon Health and Science University OHSU Cancer Institute 3181 SW Sam Jackson Park Road Portland OR 97239 USA;
MGI PHARMA INC. 5775 W. Old Shakopee Road Bloomington MN 55437 USA;
Oregon Health and Science University OHSU Cancer Institute 3181 SW Sam Jackson Park Road Portland OR 97239 USA;
Palonosetron; Multiple-day; Chemotherapy-induced nausea and vomiting; Cisplatin; Testicular cancer;
机译:阿瑞匹坦加帕洛诺司琼和地塞米松预防多日顺铂化疗患者化疗引起的恶心和呕吐
机译:口服帕洛诺司琼与IV帕洛诺司琼与地塞米松联合使用在预防以顺铂为基础的高致癌性化疗(HEC)实体瘤患者中预防化疗引起的恶心和呕吐(CINV)的疗效和安全性
机译:帕洛诺司琼(Aloxi ® sup>)和地塞米松在接受多日化疗的患者中预防急性和延迟的恶心和呕吐
机译:Acu压抑腕带对急性恶心的影响,呕吐在化疗后宫颈癌患者Margono Soekarjo医院Purwokerto博士
机译:预防急性化疗引起的儿童恶心和呕吐的阿瑞品:克服障碍
机译:口服帕洛诺司琼与IV帕洛诺司琼与地塞米松联合使用在预防以顺铂为基础的高致癌性化疗(HEC)实体瘤患者中预防化疗引起的恶心和呕吐(CINV)的疗效和安全性
机译:口服帕洛诺司琼与IV帕洛诺司琼与地塞米松联合使用在预防以顺铂为基础的高致癌性化疗(HEC)实体瘤患者中预防化疗引起的恶心和呕吐(CINV)的疗效和安全性